机构:[1]Department of Neurosurgery, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China,重点科室诊疗科室神经外科神经病学中心神经外科神经病学中心首都医科大学附属天坛医院[2]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China,[3]Department of Neurosurgery, The Second Hospital of Hebei Medical University, Hebei, China,[4]Department of Neurosurgery, Xingtai Third Hospital, Shandong, China
Objective: This study aims to investigate the clinical features, long-term outcomes, and prognostic predictors of a multicenter cohort of children with moyamoya disease. Methods: A series of 303 consecutive pediatric moyamoya disease (MMD) patients were screened in the present study. The clinical characteristics were retrospectively collected, and long-term outcomes was evaluated. Furthermore, logistic regression analyses were performed to determine the prognostic predictors for the clinical outcome. Results: The mean onset age at diagnosis was 9.4 years old. The gender ratio (girl-to-boy ratio) was 1.1:1.0. Among these 303 patients, 13 patients underwent different surgical modalities in bilateral hemispheres, while eight patients failed to follow-up, and were excluded. Therefore, a total of 282 patients were analyzed. Among these patients, 17 patients underwent combined bypass (CB), 47 patients underwent direct bypass (DB), 150 patients underwent indirect bypass (113), and 68 patients underwent conservative treatment. Furthermore, recurrent stroke events were observed in 35 patients (12.4%). The Kaplan-Meier analysis demonstrated that there was no significant difference in either ischemia or hemorrhage-free time among the different surgical modalities (P = 0.67 and 0.79, respectively). Furthermore, longer ischemia-free time was observed in the surgical group, when compared to the conservative group (P < 0.01). In addition, 82.7% (177/214) of patients who underwent surgical treatment obtained good outcomes (mRS 0-1), which were significantly higher than the rate of patients who underwent conservative treatment (52.9%, 36/68; P < 0.01). The rate of patients with improved symptoms was also significantly different (93.0 vs. 16.2%, P < 0.01). However, no significant difference was observed in the rate of good outcomes, disability, and improved symptoms among the different surgical modalities. The logistic regression analyses revealed that postoperative ischemic events were the only risk factor associated with unfavorable clinical outcome (OR:3.463; 95% CI:1.436-8.351; P < 0.01). Conclusion: CB, DB, and IB might have similar effects on long-term clinical outcome in pediatric MMD. However, surgical revascularization is superior, when compared to conservative treatment. Furthermore, postoperative ischemic events were confirmed as potential prognostic factors associated with unfavorable clinical outcome.
基金:
China National Clinical Research Center for Neurosurgical Diseases (NCRC-ND) [2015BAI12B04]
第一作者机构:[1]Department of Neurosurgery, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China,[2]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China,[3]Department of Neurosurgery, The Second Hospital of Hebei Medical University, Hebei, China,
共同第一作者:
通讯作者:
通讯机构:[1]Department of Neurosurgery, Beijing Tiantan Hospital, China National Clinical Research Center for Neurological Diseases, Capital Medical University, Beijing, China,[2]Center of Stroke, Beijing Institute for Brain Disorders, Beijing, China,
推荐引用方式(GB/T 7714):
Jun Zheng,Le-Bao Yu,Ke-Fang Dai,et al.Clinical Features, Surgical Treatment, and Long-Term Outcome of a Multicenter Cohort of Pediatric Moyamoya[J].FRONTIERS IN NEUROLOGY.2019,10(JAN):-.doi:10.3389/fneur.2019.00014.
APA:
Jun Zheng,Le-Bao Yu,Ke-Fang Dai,Yan Zhang,Rong Wang&Dong Zhang.(2019).Clinical Features, Surgical Treatment, and Long-Term Outcome of a Multicenter Cohort of Pediatric Moyamoya.FRONTIERS IN NEUROLOGY,10,(JAN)
MLA:
Jun Zheng,et al."Clinical Features, Surgical Treatment, and Long-Term Outcome of a Multicenter Cohort of Pediatric Moyamoya".FRONTIERS IN NEUROLOGY 10..JAN(2019):-